文献速递胃肠外科围术期管理与 ERAS

湖北省胃肠道肿瘤患者围手术期贫血诊治现状多中心研究

[Diagnosis and treatment status of perioperative anemia in patients with gastrointestinal neoplasms: a multi-center study in Hubei Province].
PubMed 文献 · Zhonghua Wai Ke Za Zhi · 2022-01-01

该多中心研究基于湖北省62家医院7 474例胃肠道肿瘤手术患者数据,发现术前贫血发生率38.60%、术后贫血发生率61.40%,而接受治疗比例分别仅26.86%和14.93%。术前贫血组术中输血比例、术后并发症发生率和术后住院时间均高于非贫血组。

要点

  • 胃肠道肿瘤患者术前贫血发生率38.60%,术后贫血发生率61.40%。
  • 术前贫血患者接受治疗比例26.86%,术后贫血患者仅14.93%。
  • 术前贫血组术中输血比例16.74%高于非贫血组3.05%,术后并发症发生率17.78%高于14.08%。

核心结论

  • 胃肠道肿瘤患者围手术期贫血发生率较高,术前贫血可增加术中输血需求并影响短期预后。
  • 湖北省胃肠外科医师围手术期贫血规范化治疗理念有待提高。

研究设计与样本

  • 采用网络数据库形式收集2019年湖北省15个市(州)62家医院7 474例接受手术治疗的胃肠道肿瘤患者临床病理学资料。
  • 男性4 749例,女性2 725例,中位年龄62岁(范围:17~96岁)。
  • 以入院第1次和术后第1天血红蛋白值判断术前和术后贫血,贫血定义为男性血红蛋白<120 g/L、女性<110.0 g/L。
  • 轻度贫血为90 g/L至正常,中度贫血为60至<90 g/L,重度贫血为<60 g/L。
  • 采用t检验和χ²检验进行组间比较。

主要发现

  • 全部患者术前贫血发生率为38.60%(2 885/7 474),其中轻度25.09%(1 875/7 474)、中度11.37%(850/7 474)、重度2.14%(160/7 474)。
  • 术后贫血发生率为61.40%(4 589/7 474),其中轻度48.73%(3 642/7 474)、中度12.20%(912/7 474)、重度0.47%(35/7 474)。
  • 术前贫血患者接受治疗比例为26.86%(775/2 885),术后贫血患者接受治疗比例为14.93%(685/4 589)。
  • 三级甲等、三级乙等、二级甲等医院术前贫血患者接受治疗比例分别为26.12%(649/2 485)、32.32%(85/263)、29.93%(41/137)。
  • 术前贫血组术中输血比例16.74%(483/2 885)高于非贫血组3.05%(140/4 589)(χ²=434.555,P<0.01),术后并发症发生率17.78%(513/2 885)高于非贫血组14.08%(646/4 589)(χ²=18.553,P<0.01),术后住院时间(14.1±7.3)d长于非贫血组(13.3±6.2)d(t=5.202,P<0.01)。

关键数值与推荐

  • 贫血诊断标准:男性血红蛋白<120 g/L,女性<110.0 g/L。
  • 贫血分级标准:轻度90 g/L至正常,中度60至<90 g/L,重度<60 g/L。

临床怎么用

  • 该研究描述了胃肠道肿瘤患者围手术期贫血的高发生率及低治疗比例现状。
  • 术前贫血与术中输血需求增加、术后并发症发生率升高及术后住院时间延长相关。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the incidence and treatment of perioperative anemia in patients with gastrointestinal neoplasms in Hubei Province. Methods: The clinicopathological data of 7 474 patients with gastrointestinal neoplasms in 62 hospitals in 15 cities (state) of Hubei Province in 2019 were collected in the form of network database. There were 4 749 males and 2 725 females. The median age of the patients was 62 years (range: 17 to 96 years). The hemoglobin value of the first time in hospital and the first day after operation was used as the criterion of preoperative anemia and postoperative anemia. Anemia was defined as male hemoglobin <120 g/L and female hemoglobin <110.0 g/L, mild anemia as 90 to normal, moderate anemia as 60 to <90 g/L, severe anemia as <60 g/L. The t test and χ2 test were used for inter-group comparison. Results: The overall incidence of preoperative anemia was 38.60%(2 885/7 474), and the incidences of mild anemia, moderate anemia and severe anemia were 25.09%(1 875/7 474), 11.37%(850/7 474) and 2.14%(160/7 474), respectively. The overall incidence of postoperative anemia was 61.40%(4 589/7 474). The incidence of mild anemia, moderate anemia and severe anemia were 48.73%(3 642/7 474), 12.20%(912/7 474) and 0.47%(35/7 474), respectively. The proportion of preoperative anemia patients receiving treatment was 26.86% (775/2 885), and the proportion of postoperative anemia patients receiving treatment was 14.93% (685/4 589). The proportions of preoperative anemia patients in grade ⅢA, grade ⅢB, and grade ⅡA hospitals receiving treatment were 26.12% (649/2 485), 32.32% (85/263), and 29.93% (41/137), and the proportions of postoperative anemia patients receiving treatment were 14.61% (592/4 052), 22.05% (73/331), and 9.71% (20/206). The proportion of intraoperative blood transfusion (16.74% (483/2 885) vs. 3.05% (140/4 589), χ²=434.555, P<0.01) and the incidence of postoperative complications (17.78% (513/2 885) vs. 14.08% (646/4 589), χ²=18.553, P<0.01) in the preoperative anemia group were higher than those in the non-anemia group, and the postoperative hospital stay in the preoperative anemia group was longer than that in the non-anemia group ((14.1±7.3) days vs. (13.3±6.2) days, t=5.202, P<0.01). Conclusions: The incidence of perioperative anemia in patients with gastrointestinal neoplasms is high. Preoperative anemia can increase the demand for intraoperative blood transfusion and affect the short-term prognosis of patients. At present, the concept of standardized treatment of perioperative anemia among gastrointestinal surgeons in Hubei Province needs to be improved. 目的: 了解湖北省胃肠道肿瘤患者围手术期贫血发生率及治疗现状。 方法: 采用网络数据库形式收集2019年湖北省15个市(州)62家医院7 474例接受手术治疗的胃肠道肿瘤患者的临床病理学资料。男性4 749例,女性2 725例,中位年龄62岁(范围:17~96岁)。根据患者入院第1次和术后第1天的血红蛋白值判断患者是否存在术前和术后贫血,90~<120 g/L(男性)或90~<110 g/L(女性)为轻度贫血,60~<90 g/L为中度贫血,<60 g/L为重度贫血。采用t检验或χ²检验进行组间比较。 结果: 全部患者术前贫血发生率为38.60%(2 885/7 474),术后贫血发生率为61.40%(4 589/7 474)。术前贫血患者中接受治疗的比例为26.86%(775/2 885),术后贫血患者中接受治疗的比例为14.93%(685/4 589)。三级甲等、三级乙等、二级甲等医院术前贫血患者中接受治疗的比例分别为26.12%(649/2 485)、32.32%(85/263)、29.93%(41/137),术后贫血患者中接受治疗的比例分别为14.61%(592/4 052)、22.05%(73/331)、9.71%(20/206)。术前贫血组患者术中输血比例[16.74%(483/2 885)比3.05%(140/4 589),χ²=434.555,P<0.01]和术后并发症发生率[17.78%(513/2 885)比14.08%(646/4 589),χ²=18.553,P<0.01]高于非贫血组,术前贫血组患者术后住院时间长于非贫血组[(14.1±7.3)d比(13.3±6.2)d,t=5.202,P<0.01]。 结论: 胃肠道肿瘤患者围手术期贫血发生率较高,术前贫血可增加患者术中输血需求并影响短期预后。目前湖北省胃肠外科医师的围手术期贫血规范化治疗理念有待提高。.

来源:Zhonghua Wai Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Zhang P, Jiang CQ, Xiong ZG, et al. [Diagnosis and treatment status of perioperative anemia in patients with gastrointestinal neoplasms: a multi-center study in Hubei Province]. Zhonghua Wai Ke Za Zhi. 2022. PMID: 34954944. doi:10.3760/cma.j.cn112139-20210405-00160

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。